Clinical trials: Luteal Phase Defect

Luteal Phase Defect

Progesterone in Luteal Phase Deficiency

• Withdrawn
• Age: 20 to 35 years
• Phase 3

The main objective of this study will be to assess the efficacy of natural progesterone at a daily dose of 25 mg in restoring a normal luteal phase. The primary end-point will be the ongoing pregnancy rate.

Trial name

NCT02950948

Testing

Progesterone

Sponsor

IBSA Institut Biochimique SA